Drugs / 50 mg/m2 subcutaneous daily for 5 days every 28 days
50 mg/m2 subcutaneous daily for 5 days every 28 days
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03264404 | Oct 2017 → Oct 2021 | pancreatic ductal adenocarcinoma | Susan E. Bates | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 50 mg/m2 subcutaneous daily for 5 days every 28 days | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03264404 ↗ |